PlainPatent
USPTO 2015–2025 USPTO PatentsView US Corporation

Renew Medical Inc.

USPTO PatentsView assignee record - 11 granted patents across 1 technology areas, recorded in grant years 2015–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company
Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Renew ranks #25,080 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 1 technology areas.

#25,080
of 49,997 US assignees by volume
2nd percentile
by Innovation Score (13.4/100)
2.2
avg claims per patent
-90%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R25080 · US Corporation #25,080 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-LOW · CLAIMS-SPARSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 11 grants
  • MID-PACK #25,080/49,997
  • PHOTO-FINISH Reel
  • CPC-NARROW A61F · 1 areas
  • INNOV-LOW 13.4/100
  • CLAIMS-SPARSE 2.2 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -90% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Reel, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Renew’s 13.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Renew

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Renew's Innovation Score is 13.4/100 (2nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Renew?

Each dot is one of Renew’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Renew’s own 2.2 claims/patent is at or below the 20.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Renew vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 10.910.91111.1 0102030 Granted patents (volume) Avg claims / patent Reel, Inc. - 11, 17.91ReelRelationship Science LLC - 11, 26.82Relationship Scie…Remediation Products, Inc. - 11, 22.45Remediation Produ…Renault Trucks - 11, 20.55Renault TrucksRentrak Corporation - 11, 20.36RentrakRepublic of Korea (National Forensic Service Director Ministry of Public Administration and Security) - 11, 11.18Republic of Korea…Revivicor, Inc. - 11, 17.64RevivicorRhodes Pharmaceuticals L.P. - 11, 20.91Rhodes Pharmaceut…Renew Medical Inc. - 11, 2.18Renew Medical
Renew vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Renew's grants concentrate

Renew Medical Inc. is a focused PatentsView assignee: 1 CPC subclasses with 18.2% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2015 (5 grants) versus a trough of 1 in 2018. By volume, Renew sits between Reel, Inc. and Rhodes Pharmaceuticals L.P..

Who files at Renew's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Renew holds 11 patents at rank #25,080, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Renew

By rank, the assignees closest to #25,080 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Renew's primary technology class.

Renew's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

13 2nd percentile higher than 2% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0123456 2015201620182020 1
USPTO utility patent grants by year · 2015–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Renew Medical Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 5 45.5%
2016 4 36.4%
2018 1 9.1%
2020 1 9.1%

Which technologies does Renew Medical Inc. patent most?

Top 1 of 1 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Renew Medical Inc.'s patent record in context - here's where to go next.

  • Renew Medical Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 18.2% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #25,080 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Renew Medical Inc. against Reel, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 13.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.